Literature DB >> 2303064

Effect of lomefloxacin on the normal oral and intestinal microflora.

C Edlund1, B Brismar, C E Nord.   

Abstract

Ten healthy volunteers received 400 mg of lomefloxacin orally once daily for seven days. Saliva and faecal samples were collected on days 0, 2, 4, 7, 9, 11, 14 and 21 to investigate the effect of lomefloxacin on the normal oral and intestinal microflora. The mean concentration of lomefloxacin in faeces on day 7 was 203 mg/kg, while saliva levels were low, less than 0.6 mg/l in nine of ten volunteers. Aerobic gram-negative microorganisms were almost completely eradicated, while aerobic gram-positive and anaerobic microorganisms were virtually unaffected by the lomefloxacin administration. Two weeks after lomefloxacin was discontinued, the oral and intestinal microflora had returned to normal levels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303064     DOI: 10.1007/bf01969531

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  7 in total

1.  Pharmacokinetics and tissue penetration of orally administered lomefloxacin.

Authors:  J W Stone; J M Andrews; J P Ashby; D Griggs; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

Review 2.  Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections.

Authors:  C E Nord; L Kager; A Heimdahl
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

3.  Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man.

Authors:  A Heimdahl; C E Nord
Journal:  Scand J Infect Dis       Date:  1979

4.  In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea.

Authors:  J Segreti; J A Nelson; L J Goodman; R L Kaplan; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

5.  In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.

Authors:  R Wise; J M Andrews; J P Ashby; R S Matthews
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

6.  In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.

Authors:  N X Chin; A Novelli; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

Review 7.  A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.

Authors:  C Edlund; C E Nord
Journal:  Infection       Date:  1988       Impact factor: 3.553

  7 in total
  5 in total

Review 1.  Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A N Wadworth; K L Goa
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

Review 2.  Effect of quinolones on the human intestinal microflora.

Authors:  C E Nord
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 3.  Effect of quinolones on intestinal ecology.

Authors:  C Edlund; C E Nord
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 4.  Impact of the fluoroquinolones on gastrointestinal flora.

Authors:  V Korten; B E Murray
Journal:  Drugs       Date:  1993       Impact factor: 9.546

5.  Effects of treatment with antimicrobial agents on the human colonic microflora.

Authors:  Fatemeh Rafii; John B Sutherland; Carl E Cerniglia
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.